跳至主要内容
临床试验/NL-OMON37216
NL-OMON37216尚未招募3 期

Autologous bone marrow-derived mononuclear cells for therapeutic arteriogenesis in patients with limb ischemia A double blind placebo controlled study in diabetic and non-diabetic patients - Autologous bone marrow for peripheral artery disease.

eids Universitair Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with persistent (>3 months, despite optimal treatment) disabling claudication or with critical leg ischemia (Fontaine's stages IIb-IV or Rutherford's categories 3-6) without adequate options for improvements by PTA or reconstructive surgery will be included in the study.

排除标准

  • candidates for angioplasty or bypass procedures
  • -inability to undergo bone marrow harvesting
  • -any condition in the affected limb that is anticipated to require surgical intervention in the first weeks after BM-MNC treatment

研究者

相似试验